Skip to main content
    S

    Scynexis Inc (SCYX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.90
    -0.31 (-9.66%)

    Market Cap: $31.95M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Scynexis Inc (SCYX) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Scynexis reported revenue of $20.60M for the fiscal year ended Dec 31, 2025, up 449.9% from the year before. That year, net income was -$8.61M with a net margin of -41.8%, operating cash flow was -$5.28M and free cash flow was -$5.28M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$8.46M.

    Revenue and Margins

    The operating margin was -78.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $257.00K, a compound annual rate of 62.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$20.60M+449.9%100.0%-78.0%-41.8%
    Dec 2024$3.75M-97.3%100.0%-990.8%-568.3%
    Dec 2023$140.14M+2652.7%88.9%51.9%47.8%
    Dec 2022$5.09M-61.3%100.0%-1684.5%-1233.7%
    Dec 2021$13.16MN/A100.0%-462.2%-249.7%
    Dec 2020$0-100.0%N/AN/AN/A
    Dec 2019$121.00K-52.9%100.0%-40430.6%-44388.4%
    Dec 2018$257.00K0.0%100.0%-11666.5%-4851.4%
    Dec 2017$257.00K0.0%100.0%-10241.2%-9751.0%
    Dec 2016$257.00KN/A100.0%-10823.7%-11668.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$20.60M$3.75M$140.14M$5.09M$13.16M$0$121.00K$257.00K$257.00K$257.00K
    Cost of revenue$0$0$15.62M$0$0$0$0$0$0$0
    Gross profit$20.60M$3.75M$124.52M$5.09M$13.16M$0$121.00K$257.00K$257.00K$257.00K
    Research and development$22.28M$26.41M$30.93M$27.26M$23.77M$36.52M$38.39M$21.56M$18.33M$20.08M
    Operating income-$16.07M-$37.12M$72.67M-$85.76M-$60.84M-$51.15M-$48.92M-$29.98M-$26.32M-$27.82M
    Net income-$8.61M-$21.29M$67.04M-$62.81M-$32.87M-$55.19M-$53.71M-$12.47M-$25.06M-$29.99M
    EBITDA-$10.46M-$22.49MN/A-$60.25M-$27.61MN/AN/A-$17.64M-$23.15MN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$235.00K$0$18.65M$334.00K$1.36M$257.00K$977.00K$660.00K$736.00K$1.37M$5.80M
    Gross profit$0$235.00K$0$18.65M$334.00K$1.36M$257.00K$977.00K$660.00K$736.00K$1.37M-$9.40M
    Operating income-$9.76M-$7.78M-$16.94M$10.50M-$8.40M-$9.56M-$8.61M-$8.05M-$10.32M-$9.24M-$9.51M-$23.07M
    Net income-$8.46M$7.40M-$21.30M$12.26M-$8.59M-$6.88M-$5.39M-$4.43M-$2.81M-$14.46M$411.00K-$19.59M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $483.00K by $20.78M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$59.03M$90.64M$128.41M$87.81M$119.84M$102.54M$57.15M$53.17M$45.85M$59.79M
    Current assets$40.37M$72.18M$102.12M$79.06M$109.38M$98.21M$52.40M$51.46M$44.96M$59.33M
    Cash and equivalents$21.26M$16.05M$34.05M$45.81M$104.48M$93.04M$41.92M$11.44M$11.47M$35.66M
    Total liabilities$9.65M$35.57M$55.45M$84.58M$78.58M$79.78M$44.26M$21.95M$24.44M$24.97M
    Short-term debt$483.00K$407.00K$340.00K$282.00K$70.00K$52.00K$36.00K$0$4.35M$0
    Long-term debtN/AN/A$0$34.39M$28.75M$0$11.52M$15.08M$10.30M$14.25M
    Shareholder equity$49.38M$55.08M$72.96M$3.23M$41.26M$22.76M$12.89M$31.23M$21.41M$34.82M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$67.95M$74.97M$77.63M$59.03M$51.07M$60.69M$67.92M$90.64M$99.04M$107.81M$118.25M$128.41M
    Total liabilities$8.90M$8.04M$36.32M$9.65M$14.64M$16.23M$17.38M$35.57M$40.51M$47.40M$44.15M$55.45M
    Cash and equivalents$8.23M$10.49M$36.67M$21.26M$14.80M$11.02M$6.94M$16.05M$28.73M$25.99M$35.48M$34.05M
    Shareholder equity$59.05M$66.93M$41.31M$49.38M$36.43M$44.47M$50.53M$55.08M$58.53M$60.41M$74.11M$72.96M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$5.28M-$24.01M$60.16M-$79.88M-$54.56M-$49.35M-$38.12M-$28.32M-$24.56M-$29.35M
    Capital expenditures$0$0$60.16M$9.00K$1.17M$4.00K$0$565.00K$2.00K$27.00K
    Free cash flow-$5.28M-$24.01M$0-$79.89M-$55.73M-$49.36M-$38.12M-$28.89M-$24.56M-$29.38M
    Dividends paidN/AN/AN/AN/AN/A$10.03MN/AN/A$0$0
    Share repurchases$226.00K$195.00K$117.00K$0$4.00K$208.00KN/AN/A$333.00K$2.00M
    Investing cash flow$24.31M$6.15M-$34.88M-$27.39M-$1.17M$6.47M$26.24M-$803.00K-$9.62M-$22.47M
    Financing cash flow-$14.17M-$139.00K-$36.72M$48.60M$67.12M$94.00M$42.30M$29.42M$9.99M$40.50M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$7.47M-$14.88M-$8.10M$18.40M-$8.72M-$7.50M-$7.46M-$9.91M$765.00K-$10.86M-$4.01M-$7.74M
    Capital expendituresN/AN/A$0$0$0$0$0$0$0$0$4.01M$0
    Free cash flowN/AN/A-$8.10M$18.40M-$8.72M-$7.50M-$7.46M-$9.91M$765.00K-$10.86M-$8.01M-$7.74M
    Last 12 quarters

    Frequently Asked Questions About SCYX

    What is Scynexis' annual revenue?

    Scynexis reported revenue of $20.60M for the fiscal year ended Dec 31, 2025.

    How fast is Scynexis' revenue growing?

    Revenue was up 449.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 59.4%.

    Is Scynexis profitable?

    No. Scynexis reported net income of -$8.61M for the fiscal year ended Dec 31, 2025, with a net margin of -41.8%.

    How much free cash flow does SCYX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$5.28M minus capital expenditures of $0 produced free cash flow of -$5.28M.

    How much debt does Scynexis have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $483.00K and cash and equivalents of $21.26M.